Vaccines, blood, antisera, toxins and cultures in China | The Observatory of Economic Complexity

About

Exports In 2023, China exported $1.53B in Vaccines, blood, antisera, toxins and cultures, making it the 19th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 332nd most exported product in China. The main destination of Vaccines, blood, antisera, toxins and cultures exports from China are: United States ($440M), Brazil ($144M), Germany ($85.8M), Italy ($81.8M), and Switzerland ($68.7M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of China between 2022 and 2023 were Azerbaijan ($34.5M), Germany ($19.7M), and Japan ($15.1M).

Imports In 2023, China imported $19.8B in Vaccines, blood, antisera, toxins and cultures, becoming the 4th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 17th most imported product in China. China imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($6.51B), United States ($4.02B), Switzerland ($2.79B), Singapore ($2.13B), and Germany ($1.43B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for China between 2022 and 2023 were Singapore ($2.12B), Ireland ($1.71B), and Belgium ($444M).

COMPANIES In 2024, leading companies such as Dollarama (7) and Amazon (1) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from China to the United States.

Latest Trends

December 2024

About

Overview In December 2024 China's Vaccines, blood, antisera, toxins and cultures exports accounted up to $89.2M and imports accounted up to $1.26B, resulting in a negative trade balance of $1.17B. Between December 2023 and December 2024 the exports of China's Vaccines, blood, antisera, toxins and cultures have increased by $30.3M (51.3%) from $59M to $89.2M, while imports increased by $105M (9.11%) from $1.16B to $1.26B.

Destinations In December 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States ($27.2M), Morocco ($14.6M), Nepal ($4.36M), Philippines ($4.04M), and Nicaragua ($3.73M), and were imported mostly from Switzerland ($302M), Germany ($232M), United States ($199M), Ireland ($174M), and France ($100M).

Growth In December 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Belgium ($11.5M or 29.3k%), United States ($8.73M or 82.1%), and Turkey ($3.59M or 3.28k%). In December 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Ireland ($396M or 154%), Belgium ($145M or 2.28k%), and Germany ($106M or 112%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (December 2023 - December 2024)$30.3M(51.3%)

IMPORT GROWTH (December 2023 - December 2024)$105M(9.11%)

MAIN EXPORTER (December 2024)Jiangsu Province$78.1M

MAIN DESTINATION (December 2024)United States$27.2M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for China. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download